Cefuroxima teva-ratio 250 mg comprimidos recubiertos con pelicula efg

Leaflet: information for the user

Cefuroxima Teva-ratio 250 mg film-coated tablets

Read this leaflet carefully before you start taking this medicine because

it contains important information for you.

• Keep this leaflet, as you may need to read it again.
• If you have any questions, ask your doctor or pharmacist or nurse.
• This medicine has been prescribed for you only. Do not give it to others even if they have similar symptoms to yours, as it may harm them.
• If you experience any side effects, consult your doctor or pharmacist or nurse, even if they are not listed in this leaflet. See section 4.

Cefuroxima Teva-ratio is an antibiotic used in both adults and children. It works by eliminating the bacteria that cause infections. It belongs to a group of medications calledcephalosporins.

Cefuroxima Teva-ratio is used to treat infections of:

• throat
• nasal sinuses
• middle ear
• lungs or chest
• urinary tract
• skin and soft tissues.

Cefuroxima Teva-ratio may also be used to:

• treat Lyme disease (tick-borne infection).

Your doctor may analyze the type of bacteria causing your infection and monitor whether the bacteria are sensitive to Cefuroxima Teva-ratio during treatment.

Do not take Cefuroxima Teva-ratio:

• If you are allergic to cefuroxime (as axetil) or any cephalosporin antibioticor to any of the other ingredients of this medicine (listed in section 6).
• If you have ever had a severe allergic reaction (hypersensitivity) to any other type of beta-lactam antibiotic (penicillins, monobactam, and carbapenem derivatives).

• If you think this applies to you,do not take Cefuroxima Teva-ratiountil you have consulted your doctor.
• If you have ever developed severe skin rash or skin peeling, blisters, and/or mouth ulcers after treatment with cefuroxime or any other cephalosporin antibiotic.

Be especially careful with Cefuroxima Teva-ratio:

Severe skin reactions, including Stevens-Johnson syndrome, toxic epidermal necrolysis, drug reaction with eosinophilia and systemic symptoms (DRESS), have been associated with cefuroxime treatment. Seek medical attention immediately if you notice any of the symptoms related to these severe skin reactions described in section 4.

Warnings and precautions:

Consult your doctor or pharmacist before starting to take Cefuroxima Teva-ratio

Children:

Cefuroxima Teva-ratio is not recommended for children under 3 months, as thesecurity and efficacy for this age group have not been established.

You should be aware of certain symptoms such as allergic reactions, fungal infections (such asCandida) and severe diarrhea (pseudomembranous colitis) while taking Cefuroxima Teva-ratio. This will reduce the risk of possible complications. See“Symptoms to be aware of”in section 4.

If you need a blood test:

Cefuroxima Teva-ratio may affect the results of blood sugar levels or theCoomb test.If you need a blood test:

• Inform the person performing the testthat you are taking cefuroxime.

Taking Cefuroxima Teva-ratio with other medicines:

Inform your doctor or pharmacist if you are taking, have taken recently or may need to take any other medicine.

Medicines used toreduce stomach acid(e.g.antacidsfor treatingheartburn) may affect the mechanism of action of Cefuroxima Teva-ratio.

Probenecid

Oral anticoagulants

• Inform your doctor or pharmacistif you are taking any of these medicines.

Birth control pill:

Cefuroxima Teva-ratio may reduce the effectiveness of the birth control pill. If you are taking the birth control pill while taking cefuroxime, you should use additionalbarrier methods of contraception(such as condoms). Consult your doctor.

Pregnancy, breastfeeding, and fertility:

If you are pregnant, or breastfeeding, think you may be pregnant, or intend to become pregnant, consult your doctor or pharmacist before using this medicine.

Your doctor will assess the benefit of being treated with Cefuroxima Teva-ratio against the risk to your child.

Driving and operating machinery:

Cefuroxima Teva-ratiomay cause dizzinessand other adverse effects that may impair your ability to be alert.

• Do not drive or operate machineryif you are not feeling well

Cefuroxima Teva-ratio contains sodium:

This medicine contains less than 1mmol of sodium (23 mg) per tablet; it is essentially “sodium-free”.

.

Follow exactly the administration instructions of this medication indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.

Take Cefuroxima Teva-ratio after meals.This will help make the treatment more effective.

Swallow the Cefuroxima Teva-ratio tablets whole with water.

Do not chew, crush or divide the tablets— this may make the treatment less effective.

The recommended dose is:

Adults

The recommended dose of Cefuroxima Teva-ratio is 250 mg to 500 mg twice a day, depending on the severity and type of infection.

Use in children

The recommended dose of Cefuroxima Teva-ratio is 10 mg/kg of the child's weight (up to a maximum of 125 mg) to 15 mg/kg of the child's weight (up to a maximum of 250 mg) twice a day, depending on:

• the severity and type of infection

Cefuroxima Teva-ratio is not recommended in children under 3 months, as the safety and efficacy for this group of patients is unknown.

Depending on the disease and how you or your child responds to treatment, the initial dose may be adjusted or it may be necessary to administer more than one treatment cycle.

Patients with kidney problems

If you have kidney problems, your doctor may change your dose.

• Consult your doctorif you are affected by this problem.

If you take more Cefuroxima Teva-ratio than you should

If you take too much Cefuroxima Teva-ratio you may experience neurological disturbances, particularly you may be more likely to haveseizures (convulsions).

• Do not delay. Contact your doctor immediately or go to the nearest hospital emergency department. If possible, show them the Cefuroxima Teva-ratio packaging.

In case of overdose or accidental ingestion consult your doctor or pharmacist immediately or callthe Toxicological Information Service phone 91 562 04 20, indicating the medication and the amount ingested.

If you forgot to take Cefuroxima Teva-ratio

Do not take a double dose to compensate for the missed doses.Simply continue with the next dose as usual.

If you interrupt the treatment with Cefuroxima Teva-ratio

Do not interrupt the treatment with Cefuroxima Teva-ratio without prior advice.

It is essential that you complete the entire Cefuroxima Teva-ratio treatment.Do not interrupt it unless your doctor tells you to, even if you have started to feel better. If you do not complete the treatment cycle, the infection may recur.

If you have any other doubts about the use of this medication, ask your doctor or pharmacist

Like all medicines, this medicine can cause side effects, although not everyone will experience them.

Symptoms you should be aware of

A small number of people who took cefuroxime reported an allergic reaction or a potentially severe skin reaction. The symptoms of these reactions include:

• Severe allergic reaction. The signs includeskin rash with itching, swelling, sometimes on the face or mouth, causingdifficulty breathing
• Skin rash,which may causeblistering,which appear likesmall dots(dark spot in the center surrounded by a lighter area, with a dark ring around the edge)
• Widespread skin rash withblistering and skin peeling.(These may be symptoms ofStevens-Johnson SyndromeorToxic Epidermal Necrolysis)
• Generalized rash, high body temperature, and swollen lymph nodes.(DRESS or drug hypersensitivity syndrome)
• Chest pain in the context of allergic reactions, which may be a symptom of an allergic-induced heart attack.(Kounis syndrome).

Other symptoms you should be aware of while taking cefuroxime:

• Fungal infections.Cefuroxime Teva-ratio may cause an increase in fungal growth (Candida), in the body that may lead to fungal infections (such as thrush). This side effect is more likely to occur if cefuroxime has been taken for a prolonged period
• Severe diarrhea (Pseudomembranous Colitis).Cefuroxime Teva-ratio may cause inflammation of the colon (large intestine), which produces severe diarrhea, usually accompanied by blood and mucus, abdominal pain, and fever
• Jarisch-Herxheimer reaction.Some patients may experience an increase in body temperature (fever), chills, headache, muscle pain, and skin rash while taking Cefuroxime Teva-ratio to treat Lyme disease. This is known asJarisch-Herxheimer reaction.The symptoms usually last for a few hours to a day.

• Contact a doctor or nurse immediately if you experience any of these symptoms.

Common side effects

May affectup to 1 in 10patients:

• Fungal infection (such asCandida)
• Headache
• Dizziness
• Diarrhea
• Nausea
• Abdominal pain.

Common side effects that may appear in blood tests:

• Increased count of a type of white blood cell (eosinophilia)
• Increased levels of liver enzymes.

Uncommon side effects

May affectup to 1 in 100patients:

• Vomiting
• Skin rash.

Uncommon side effects that may appear in blood tests:

• Decreased number of platelets in the blood (cells that help blood to clot)
• Decreased number of white blood cells
• Positive Coomb test.

Other side effects

Other side effects have occurred in a very small number of people, but their exact frequency is unknown:

• Severe diarrhea (Pseudomembranous Colitis)
• Allergic reactions
• Skin rash (which may be severe)
• High fever
• Yellowing of the white of the eyes or skin
• Inflammation of the liver (hepatitis).

Side effects that may appear in blood tests:

• Rapid destruction of red blood cells (hemolytic anemia).

Reporting side effects

If you experience any type of side effect, consult your doctor or pharmacist, even if it is a side effect that does not appear in this leaflet. You can also report them directly through the Spanish System for the Vigilance of Medicinal Products for Human Use:www.notificaRAM.es.

By reporting side effects, you can contribute to providing more information on the safety of this medicine.

No requires special conditions for conservation

Keep this medication out of the sight and reach of children.

Do not use this medication after the expiration date that appears on the packaging after CAD. The expiration date is the last day of the month indicated.

Medicines should not be thrown down the drain or in the trash. Dispose of the packaging and medications you no longer need at the SIGRE collection point of the pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and medications you no longer need. In this way, you will help protect the environment.

Composition of Cefuroxima Teva-ratio

• The active ingredient is cefuroxima. Each tablet contains 250 mg of cefuroxima (as axetilo).
• The other components (excipients) are: pregelatinized corn starch, croscarmelosa sodium (AC-Disol SD-711), sodium laurilsulfate, microcrystalline cellulose, anhydrous colloidal silica, hydrogenated vegetable oil, Opadry.

Appearance of the product and contents of the packaging

Blue-colored, biconvex, capsule-shaped tablets with a film coating. Each box contains 10, 15, 20, or 500 film-coated tablets.

Only some packaging sizes may be commercially available.

Holder of the marketing authorization and responsible for manufacturing

Holder of marketing authorization

Teva Pharma, S.L.U.

C/ Anabel Segura, Edificio Albatros B, 1st floor

28108 Alcobendas, Madrid (Spain)

Responsible for manufacturing:

Toll Manufacturing Services, S.L.

Aragoneses, 2

28108- Alcobendas-Madrid

Spain

or

FARMALIDER S.A

C/ Aragoneses 2

28108 - Alcobendas (Madrid)

Spain

or

Laboratórios Atral SA

Rua da Estação, 1 e 1A

2600-726 Castanheira do Ribatejo Portugal

Last review date of this leaflet: May 2023

Detailed and updated information about this medicine is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS) http://www.aemps.gob.es

You can access detailed and updated information about this medicine by scanning the QR code included in the packaging with your smartphone. You can also access this information at the following internet address: https://cima.aemps.es/cima/dochtml/p/69954/P_69954.html

QR+URL